Clinical Trials on Locally Advanced Breast Cancer (LABC)
Total 14330 results
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
Institut Paoli-CalmettesNovartis PharmaceuticalsRecruitingAdvanced or Metastatic Breast Cancer (BC)France
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownHormone Receptor Positive Advanced Breast CancerChina
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityGuangzhou Anjie Biomedical Technology Co., Ltd.CompletedAdvanced Breast Cancer | Breast Neoplasm Malignant FemaleChina
-
Zhejiang Cancer HospitalRecruitingHER2-positive Advanced Breast CancerChina
-
AstraZenecaCompletedAdvanced and Metastatic Breast CancerUnited States, United Kingdom
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Luye Pharma Group Ltd.CompletedAdvanced Breast CancerChina
-
Spanish Breast Cancer Research GroupRoche Farma, S.ACompleted
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Tianjin Medical University Cancer Institute and...CompletedPyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerHER2-positive Advanced Breast CancerChina
-
University of Texas Southwestern Medical CenterUniversity of Pennsylvania; PfizerCompletedAdvanced Breast CancerUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Non-small Cell Lung CancerChina
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
Eisai Inc.CompletedLocally Recurrent | Metastatic Breast Cancer ( HER2 Negative)United States
-
Northwest BiotherapeuticsUnknownMelanoma | Colorectal Cancer | Pancreatic Cancer | Liver Cancer | Locally Advanced Tumor | Metastatic Solid Tissue TumorsUnited States
-
Academisch Ziekenhuis MaastrichtEli Lilly and Company; Novartis; Pfizer; Gilead Sciences; Roche Pharma AG; AstraZeneca and other collaboratorsRecruitingAdvanced Breast Cancer | Metastatic Breast CancerNetherlands
-
Neovii BiotechFresenius Biotech North AmericaTerminatedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
National Cancer Institute (NCI)Not yet recruitingMetastatic Melanoma | Locally Advanced Melanoma | Metastatic Alveolar Soft Part Sarcoma | Metastatic Non Small Cell Lung Cancer | Metastatic Hepatocellular Carcinoma | Locally Advanced Hepatocellular Carcinoma | Metastatic Small Cell Lung Cancer | Locally Advanced Non Small Cell Lung Cancer | Locally... and other conditionsUnited States
-
Unity Health TorontoHoffmann-La RocheUnknownStage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic)Canada
-
University of MiamiNational Cancer Institute (NCI)Not yet recruitingAdvanced Breast Cancer | HER2-positive Breast CancerUnited States
-
ChimerixWithdrawnAdvanced Colorectal Cancer | Advanced Glioblastoma | Advanced Triple-negative Breast Cancer | Advanced Non-small Cell Lung CancerUnited States
-
Fujian Cancer HospitalNot yet recruitingAdvanced Triple Negative Breast CancerChina
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingOther Solid Tumors | Locally Advanced or Metastatic Digestive Tract TumorsChina
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
GERCOR - Multidisciplinary Oncology Cooperative...OSE ImmunotherapeuticsRecruitingMetastatic Cancer | Pancreatic Ductal Adenocarcinoma | Locally Advanced CancerFrance
-
Lund University HospitalCompletedLocally Advanced Head and Neck CancerSweden
-
Reshma L. Mahtani, D.O.Gilead SciencesRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
Kind Pharmaceuticals LLCRecruitingAdvanced or Metastatic Breast CancerUnited States
-
Zhiyong YuNot yet recruitingHER2-positive Advanced Breast Cancer
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Breast CancerChina
-
Adlai Nortye Biopharma Co., Ltd.CompletedAdvanced or Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedER+ / HER2- Advanced Breast CancerChina
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingAdvanced Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Low Advanced or Metastatic Breast Cancer
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingHR-positive, HER2-negative Advanced Breast CancerChina
-
Immunicom IncRecruitingAdvanced Breast CancerPoland, Turkey
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
Samsung Medical CenterKorean Cancer Study GroupCompletedAdvanced Breast CancerKorea, Republic of